InsiderClue
Stocks · Health care · Pharmaceutical Preparations

CUMBERLAND PHARMACEUTICALS INC

CPIX Clue Score47
United States Fiscal year ends December CIK 0001087294
$7.03 +0.72% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.03 +159.41% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue32.5Operating income−1.4Net income−0.9EPS, diluted−0.06Fiscal year 2017Revenue40.4 +24.3%Operating income−4.1Net income−8.0EPS, diluted−0.50Fiscal year 2018Revenue28.8 −28.7%Operating income−11.2Net income−7.0EPS, diluted−0.45Fiscal year 2019Revenue32.4 +12.5%Operating income−9.3Net income−3.5EPS, diluted−0.23Fiscal year 2020Revenue35.8 +10.6%Operating income−6.4Net income−3.3EPS, diluted−0.22Fiscal year 2021Revenue35.0 −2.2%Operating income−7.7Net income−3.5EPS, diluted−0.24Fiscal year 2022Revenue42.0 +19.9%Operating income−5.7Net income−5.6EPS, diluted−0.38Fiscal year 2023Revenue39.6 −5.9%Operating income−9.6Net income−6.3EPS, diluted−0.44Fiscal year 2024Revenue37.9 −4.3%Operating income−6.4Net income−6.5EPS, diluted−0.46Fiscal year 2025Revenue44.5 +17.6%Operating income−2.8Net income−2.8EPS, diluted−0.19
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 32.5 40.4 28.8 32.4 35.8 35.0 42.0 39.6 37.9 44.5
Growth +24.3% −28.7% +12.5% +10.6% −2.2% +19.9% −5.9% −4.3% +17.6%
Operating income −1.4 −4.1 −11.2 −9.3 −6.4 −7.7 −5.7 −9.6 −6.4 −2.8
Net income −0.9 −8.0 −7.0 −3.5 −3.3 −3.5 −5.6 −6.3 −6.5 −2.8
Growth
EPS, diluted −0.06 −0.50 −0.45 −0.23 −0.22 −0.24 −0.38 −0.44 −0.46 −0.19
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−4.4%Net margin−2.9%Free cash flow margin1.4%Fiscal year 2017Operating margin−10.1%Net margin−19.8%Free cash flow margin−2.1%Fiscal year 2018Operating margin−38.8%Net margin−24.2%Free cash flow margin9.2%Fiscal year 2019Operating margin−28.7%Net margin−10.9%Free cash flow margin8.7%Fiscal year 2020Operating margin−17.8%Net margin−9.3%Free cash flow margin14.7%Fiscal year 2021Operating margin−21.9%Net margin−10.0%Free cash flow margin17.8%Fiscal year 2022Operating margin−13.6%Net margin−13.3%Free cash flow margin19.9%Fiscal year 2023Operating margin−24.2%Net margin−15.9%Free cash flow margin14.7%Fiscal year 2024Operating margin−17.0%Net margin−17.1%Free cash flow margin−1.8%Fiscal year 2025Operating margin−6.3%Net margin−6.4%Free cash flow margin10.9%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −4.4% −10.1% −38.8% −28.7% −17.8% −21.9% −13.6% −24.2% −17.0% −6.3%
Net margin −2.9% −19.8% −24.2% −10.9% −9.3% −10.0% −13.3% −15.9% −17.1% −6.4%
Free cash flow margin 1.4% −2.1% 9.2% 8.7% 14.7% 17.8% 19.9% 14.7% −1.8% 10.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow0.6Capital expenditure−0.1Free cash flow0.4Buybacks−2.5Fiscal year 2017Operating cash flow−0.6Capital expenditure−0.3Free cash flow−0.8 −290.1%Buybacks−3.7Fiscal year 2018Operating cash flow3.1Capital expenditure−0.5Free cash flow2.7Buybacks−2.9Fiscal year 2019Operating cash flow3.1Capital expenditure−0.2Free cash flow2.8 +5.8%Buybacks−3.5Fiscal year 2020Operating cash flow5.4Capital expenditure−0.1Free cash flow5.3 +87.7%Buybacks−1.9Fiscal year 2021Operating cash flow6.3Capital expenditure−0.1Free cash flow6.2 +18.3%Buybacks−1.4Fiscal year 2022Operating cash flow8.5Capital expenditure−0.1Free cash flow8.4 +33.9%Buybacks−1.1Fiscal year 2023Operating cash flow6.1Capital expenditure−0.3Free cash flow5.8 −30.4%Buybacks−0.7Fiscal year 2024Operating cash flow−0.6Capital expenditure−0.1Free cash flow−0.7 −111.7%Buybacks−0.6Fiscal year 2025Operating cash flow4.9Capital expenditure−0.1Free cash flow4.8Buybacks−0.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 0.6 −0.6 3.1 3.1 5.4 6.3 8.5 6.1 −0.6 4.9
Capital expenditure −0.1 −0.3 −0.5 −0.2 −0.1 −0.1 −0.1 −0.3 −0.1 −0.1
Free cash flow 0.4 −0.8 2.7 2.8 5.3 6.2 8.4 5.8 −0.7 4.8
Growth −290.1% +5.8% +87.7% +18.3% +33.9% −30.4% −111.7%
Buybacks −2.5 −3.7 −2.9 −3.5 −1.9 −1.4 −1.1 −0.7 −0.6 −0.3

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash34.5Shareholders’ equity73.2Fiscal year 2017Cash45.4Shareholders’ equity64.1Fiscal year 2018Cash27.9Shareholders’ equity55.8Fiscal year 2019Cash28.2Shareholders’ equity51.1Fiscal year 2020Cash24.8Shareholders’ equity47.0Fiscal year 2021Cash27.0Shareholders’ equity42.8Fiscal year 2022Cash19.8Shareholders’ equity36.3Fiscal year 2023Cash18.3Total debt0.0Net cash (debt)18.3Shareholders’ equity29.6Debt to equity0.00Fiscal year 2024Cash18.0Total debt5.1Net cash (debt)12.9Shareholders’ equity22.9Debt to equity0.22Fiscal year 2025Cash11.4Total debt0.0Net cash (debt)11.4Shareholders’ equity24.9Debt to equity0.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 34.5 45.4 27.9 28.2 24.8 27.0 19.8 18.3 18.0 11.4
Total debt n/a n/a n/a n/a n/a n/a n/a 0.0 5.1 0.0
Net cash (debt) n/a n/a n/a n/a n/a n/a n/a 18.3 12.9 11.4
Shareholders’ equity 73.2 64.1 55.8 51.1 47.0 42.8 36.3 29.6 22.9 24.9
Debt to equity n/a n/a n/a n/a n/a n/a n/a 0.00 0.22 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
32.5 40.4 28.8 32.4 35.8 35.0 42.0 39.6 37.9 44.5
Growth +24.3% −28.7% +12.5% +10.6% −2.2% +19.9% −5.9% −4.3% +17.6%
6.0 7.4 6.0 7.4 8.7 8.8 9.1 6.1 6.6 6.7
3.2 4.3 7.6 6.9 5.8 5.7 6.7 5.8 4.8 5.6
8.6 9.7 10.2 10.0 10.2 9.8 10.2 10.7 11.1 11.9
−1.4 −4.1 −11.2 −9.3 −6.4 −7.7 −5.7 −9.6 −6.4 −2.8
Growth
−1.3 −3.9 −10.8 −9.3 −6.6 −5.6 −5.6 −6.3 −6.5 −2.8
−0.3 4.2 0.0 −0.1 0.1 0.0 0.1 0.0 −0.0 0.0
−0.9 −8.0 −7.0 −3.5 −3.3 −3.5 −5.6 −6.3 −6.5 −2.8
Growth
Per share
−0.06 −0.50 −0.45 −0.23 −0.22 −0.24 −0.38 −0.44 −0.46 −0.19
−0.06 −0.50 −0.45 −0.23 −0.22 −0.24 −0.38 −0.44 −0.46 −0.19
Growth
16.2 15.9 15.6 15.4 15.2 14.9 14.6 14.3 14.1 14.9
16.2 15.9 15.6 15.4 15.2 14.9 14.6 14.3 14.1 14.9
Growth −2.0% −1.9% −1.4% −1.5% −1.7% −2.3% −1.8% −1.7% +5.6%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 4.4% a year over five years.
  • The diluted share count fell 2.0% in five years, so buybacks did some of the work per share.
  • Operating margin is up 11.5 points on five years ago, at -6.3%.
  • A net loss in 10 of 10 years on file.